The estimated Net Worth of Lucia Luce Quinn is at least $6.71 millió dollars as of 3 August 2018. Ms. Quinn owns over 1,250 units of UFP Technologies stock worth over $6,589,829 and over the last 17 years she sold UFPT stock worth over $0. In addition, she makes $116,250 as Independent Director at UFP Technologies.
Sign up
Ms. Quinn UFPT stock SEC Form 4 insiders trading
Lucia has made over 15 trades of the UFP Technologies stock since 2008, according to the Form 4 filled with the SEC. Most recently she exercised 1,250 units of UFPT stock worth $371,350 on 3 August 2018.
The largest trade she's ever made was exercising 16,773 units of UFP Technologies stock on 12 February 2009 worth over $4,982,923. On average, Lucia trades about 2,191 units every 133 days since 2008. As of 3 August 2018 she still owns at least 22,182 units of UFP Technologies stock.
You can see the complete history of Ms. Quinn stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Lucia Quinn biography
Lucia Luce Quinn serves as Independent Director of the Company. Ms. Quinn has served as a director of the Company since December 2013. In early 2019, Ms. Quinn accepted a position as Chief People Officer at WuXi NextCODE, an integrated global life sciences informatics company that serves the leading population genomics, precision medicine, diagnostics and wellness initiatives and enterprises with the most proven and widely used technology for organizing, mining and sharing genome sequence data. In October 2016, Ms. Quinn accepted the position of Strategic Advisor at Shepley Bulfinch, a national architecture firm. Previously, Ms. Quinn served as Chief People Officer of Forrester Research, Inc., a $340 million global research and advisory firm from June 2013 until 2018. From June 2012 through May 2013, Ms. Quinn consulted with Truepoint Partners, a strategic planning and organization development consulting firm. From June 2010 through April 2012 Ms. Quinn was Senior Vice President, Global Human Resources and Corporate Affairs for Convatec, Inc., a $1.6 billion medical device and products company. From March 2005 through September 2009 Ms. Quinn was Executive Vice President, BSC Global Human Resources at Boston Scientific, an $8 billion medical solutions provider. Prior to that, Ms. Quinn served in various leadership and operations capacities at Quest Diagnostics, AlliedSignal/Honeywell, Digital Equipment Corp. and Westinghouse Electric Corp. Ms. Quinn also served as a trustee of Simmons College from 1996 to 2011, including chairing the Technology and Executive Compensation committees and serving as Chair of the Board of Trustees for five years. Ms. Quinn possesses particular knowledge and experience in human resources, strategic planning and leadership consulting for complex organizations that strengthen the Board's collective qualifications, skills, and experience.
What is the salary of Lucia Quinn?
As the Independent Director of UFP Technologies, the total compensation of Lucia Quinn at UFP Technologies is $116,250. There are 11 executives at UFP Technologies getting paid more, with R. Jeffrey Bailly having the highest compensation of $2,325,980.
How old is Lucia Quinn?
Lucia Quinn is 66, she's been the Independent Director of UFP Technologies since 2013. There are 1 older and 12 younger executives at UFP Technologies. The oldest executive at UFP Technologies Inc. is Cynthia Feldmann, 67, who is the Independent Director.
What's Lucia Quinn's mailing address?
Lucia's mailing address filed with the SEC is C/O UFP TECHNOLOGIES, INC., 100 HALE STREET, NEWBURYPORT, MA, 01950.
Insiders trading at UFP Technologies
Over the last 21 years, insiders at UFP Technologies have traded over $115,201,423 worth of UFP Technologies stock and bought 293,413 units worth $1,574,519 . The most active insiders traders include R Jeffrey Bailly, Peter R Worrell és Richard L Bailly. On average, UFP Technologies executives and independent directors trade stock every 22 days with the average trade being worth of $4,358,758. The most recent stock trade was executed by Ronald J Lataille on 23 August 2024, trading 2,392 units of UFPT stock currently worth $787,064.
What does UFP Technologies do?
ufp technologies is a producer of innovative custom-engineered components, products, and specialty packaging. founded in 1963 and headquartered in newburyport, massachusetts, our company has pioneered a long list of processes and applications, has a large portfolio of active patents, and holds proprietary positions on many advanced materials from leading global suppliers. with a deep and accomplished engineering team, ufp technologies is a critical link in the value chain between raw material suppliers and oems. our team acts as an extension of customers' in-house research, engineering and manufacturing groups, working closely with them to solve their most complex product and packaging challenges. using foams, plastics, composites, and natural fiber materials, we design and manufacture a vast range of solutions primarily for six target markets including medical, automotive, aerospace & defense, electronics, consumer and industrial.
What does UFP Technologies's logo look like?
Complete history of Ms. Quinn stock trades at Forrester Research, UFP Technologies és Boston Scientific
UFP Technologies executives and stock owners
UFP Technologies executives and other stock owners filed with the SEC include:
-
R. Jeffrey Bailly,
Chairman of the Board, President, Chief Executive Officer -
R. Jeffrey Bailly,
Chairman, Pres & CEO -
Ronald Lataille,
Chief Financial Officer, Senior Vice President, Treasurer -
Mitchell Rock,
Senior Vice President of Sales and Marketing -
Christopher Litterio,
Senior Vice President of Human Resources, General Counsel, Secretary -
Ronald J. Lataille,
CFO, Sr. VP & Treasurer -
Mitchell Caplan Rock,
Sr. VP of Sales & Marketing and GM of Medical -
Christopher P. Litterio Esq.,
Gen. Counsel, Sec. & Sr. VP of HR -
Daniel Shaw,
Vice President - Research & Development -
Marc Kozin,
Lead Independent Director -
Cynthia Feldmann,
Independent Director -
Lucia Quinn,
Independent Director -
Robert Pierce,
Independent Director -
Thomas Oberdorf,
Independent Director -
Daniel Croteau,
Independent Director -
Steve Cardin,
VP & COO of MedTech -
W David Smith,
Vice President -
David K Stevenson,
Director -
Micahel J Ross,
Director -
Kenneth L Gestal,
Director -
David Bartlett Gould,
Director -
Richard Lesavoy,
Vice President -
Avenue Capital, Llc Yorktown,
10% owner -
William Shaw,
chairman -
Peter R Worrell,
Director -
William C Curry,
Director -
Wayne G Williams,
Vice President -
Richard L Bailly,
Director -
Jason Holt,
Vice President -
Steve Cardin,
Vice President -
Symeria Hudson,
Director -
Joseph Hassett,
Director